Avai Bio, Inc.

OTC: AVAI · Technology · Software - Application

PublicHQ Vilnius, NVCIK 0001740797Reports USD

#900 of 1,124 Technology companies by revenue

EA Score

——

FH 14DQ —GM —SS 26

v0.1 · 35/100 weight · pillars only

↑ market scale, listing tenure · ↓ workforce scale, disclosure history

Methodology →

Revenue TTM

$276.3k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.7M

Employees

Market cap

$18.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$276.3k$276.3k2024

Net income-$1.7M-$1.7M2026

Operating income-$1.7M-$1.7M2026

Total assets$572.7k$572.7k2026

Liabilities$3.4M$3.4M2026

Equity-$2.8M-$2.8M2026

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Avai Bio, Inc. booked $276.3k in FY2024 revenue — among the slowest-growing Technology companies we track, at a -633.1% net margin.

Peers · Technology

FalconStor Software, Inc.——Prospect Prediction Markets Inc.——Cyberloq Technologies, Inc.34D The Glimpse Group, Inc.43D

Key facts

CEOChris Winter

SectorTechnology

IndustrySoftware - Application

HeadquartersVilnius, NV

ExchangeOTC: AVAI

Employees1

IPO date2020-04-06

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.